BIA
JAZZ icon

Bell Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bell Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.06K Buy
21
+2
+11% +$438 ﹤0.01% 972
2026
Q1 		$3.59K Sell
19
-3
-14% -$524 ﹤0.01% 1104
2025
Q4 		$3.74K Buy
22
+3
+16% +$460 ﹤0.01% 1095
2025
Q3 		$2.5K Sell
19
-34
-64% -$4.08K ﹤0.01% 1245
2025
Q2 		$5.63K Sell
53
-5
-9% -$543 ﹤0.01% 931
2025
Q1 		$7.2K Hold
58
– – ﹤0.01% 736
2024
Q4 		$7.14K Buy
58
+44
+314% +$5.19K ﹤0.01% 749
2024
Q3 		$1.56K Sell
14
-11
-44% -$1.21K ﹤0.01% 1447
2024
Q2 		$2.67K Buy
25
+21
+525% +$2.31K ﹤0.01% 1237
2024
Q1 		$482 Hold
4
– – ﹤0.01% 1835
2023
Q4 		$492 Sell
4
-46
-92% -$5.74K ﹤0.01% 1838
2023
Q3 		$6.47K Buy
50
+4
+9% +$533 ﹤0.01% 686
2023
Q2 		$5.7K Sell
46
-3
-6% -$404 ﹤0.01% 747
2023
Q1 		$7.17K Sell
49
-3
-6% -$444 ﹤0.01% 609
2022
Q4 		$8.28K Buy
52
+33
+174% +$4.84K ﹤0.01% 562
2022
Q3 		$3K Sell
19
-7
-27% -$1.06K ﹤0.01% 926
2022
Q2 		$4K Buy
+26
New +$4K ﹤0.01% 810
2021
Q4 		$2K Buy
15
+3
+25% +$394 ﹤0.01% 1163
2021
Q3 		$2K Buy
+12
New +$1.81K ﹤0.01% 1089

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bell Investment Advisors's JAZZ Position: Q2 2026 in Review

Bell Investment Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q2 2026, buying an estimated $438 and bringing the position to 21 shares worth $5.06K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Bell Investment Advisors first reported a position in JAZZ in Q3 2021 and has held it in 19 quarters since. The position peaked at $8.28K in Q4 2022. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Bell Investment Advisors held 21 shares of Jazz Pharmaceuticals worth $5.06K as of Q2 2026.
  • Bell Investment Advisors bought 2 Jazz Pharmaceuticals shares in Q2 2026, an estimated $438.
  • Jazz Pharmaceuticals made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #972 holding.
  • Bell Investment Advisors first reported a position in Jazz Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Jazz Pharmaceuticals position peaked at $8.28K in Q4 2022.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.